Kintara Therapeutics Stock Quote KTRA - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

7.539

Bid

0.2199

Ask

0.22

Volume

0.00 Day's Range 0.00

2.835 52 Week Range 17.3635

Market Cap

419.625M

Previous Close

7.539

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

2,149,083

Shares Outstanding

55,660,578

Dividend Yield

PE Ratio

-49.38

Earnings Per Share (EPS)

-0.15

Revenue

Net Profit

-8.5M

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and ... Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kintara.com

Headquarters

Reno, Nevada, USA

Founded

Kintara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KTRA. The last closing price for Kintara Therapeutics was $7.54. Over the last year, Kintara Therapeutics shares have traded in a share price range of $ 2.835 to $ 17.3635.

Kintara Therapeutics currently has 55,660,578 shares outstanding. The market capitalization of Kintara Therapeutics is $419.63 million. Kintara Therapeutics has a price to earnings ratio (PE ratio) of -49.38.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	7.539	7.539	7.539	0	0	CS
4	0	0	7.539	7.539	7.539	0	0	CS
12	0.7595	11.2028910687	6.7795	8.3965	5.4355	2149083	6.79561776	CS
26	1.288	20.6047032475	6.251	14.595	5.278	5692982	8.71818939	CS
52	-4.7355	-38.5799828914	12.2745	17.3635	2.835	8464731	6.21178682	CS
156	-1374.961	-99.4546835443	1382.5	1470	2.835	3633352	94.09540966	CS
260	-2109.961	-99.6439669421	2117.5	5862.5	2.835	2862508	368.07818439	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	$ 8.26 (89.02%)	2.03M
XCURExicure Inc	$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	$ 0.0201 (-0.50%)	415.87M
NVDANVIDIA Corporation	$ 141.95 (-3.22%)	229.93M
SMCISuper Micro Computer Inc	$ 33.15 (11.62%)	155.43M
VRPXVirpax Pharmaceuticals Inc	$ 0.5501 (-6.72%)	154.17M
SOUNSoundHound AI Inc	$ 8.24 (18.05%)	103.6M